Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan^® treatment of onchocerciasis in Loa loa endemic areas.

Report of a Scientific Working Group on Serious Adverse Events following Mectizan^® treatment of onchocerciasis in Loa loa endemic areas

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis

Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future

Ivermectin: does P-glycoprotein play a role in neurotoxicity?

A Framework for Decision-Making for Mass Distribution of Mectizan^® in Areas Endemic for Loa loa

Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis